Anebulo Pharmaceuticals, Inc. ANEB
0.24 USD -0.02 (-6.92%)
At closeOct 30, 2026, 4:00 PM EDT
0.38 +0.14 +57.81%
After hours · Oct 30, 4:00 PM ET
0.8699 Day range 0.8699
0.001 52-week range 2.56
- YTD
- -76.04%
- 1 year
- -90.83%
Analyst view
Price target (mean) 8.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.08 – -0.08 | -0.11 | +27.3% | 0 | 0.0% | 1 |
| Next quarter | -0.08 | -0.08 – -0.08 | -0.06 | -33.3% | 0 | 0.0% | 1 |
| Current year | -0.33 | -0.33 – -0.33 | 0.00 | 0.0% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Oct 1, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Oct 3, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Sep 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 21, 2023 | Maxim Group | Initiated | — | Buy |
| Sep 18, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| May 18, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Feb 14, 2023 | Benchmark | Maintained | — | Speculative Buy |
| Jul 27, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| May 25, 2021 | Benchmark | Initiated | — | Buy |